Reprogramming cancer into antigen presenting cells as a novel immunotherapy

Placeholder Show Content

Abstract/Contents

Abstract
Therapeutic cancer vaccination seeks to elicit activation of tumor-reactive T cells capable of recognizing tumor-associated antigens (TAAs) and eradicating malignant cells. Here, we present a cancer vaccination approach utilizing myeloid lineage reprogramming to directly convert cancer cells into tumor reprogrammed-APCs (TR-APCs). Using syngeneic murine leukemia models, we demonstrate that TR-APCs acquire both myeloid phenotype and function, process and present endogenous TAAs, and potently stimulate TAA-specific CD4+ and CD8+ T cells. In vivo TR-APC induction elicits clonal expansion of cancer-specific T cells, establishes cancer-specific immune memory, and ultimately promotes leukemia eradication. We further show that both hematologic cancers and solid tumors, including sarcomas and carcinomas, are amenable to myeloid-lineage reprogramming into TR-APCs. Finally, we demonstrate the clinical applicability of this approach by generating TR-APCs from primary clinical specimens and stimulating autologous patient-derived T cells. Thus, TR-APCs represent a cancer vaccination therapeutic strategy with broad implications for clinical immuno-oncology.

Description

Type of resource text
Form electronic resource; remote; computer; online resource
Extent 1 online resource.
Place California
Place [Stanford, California]
Publisher [Stanford University]
Copyright date 2022; ©2022
Publication date 2022; 2022
Issuance monographic
Language English

Creators/Contributors

Author Linde, Miles Hamilton
Degree supervisor Majeti, Ravindra, 1972-
Thesis advisor Majeti, Ravindra, 1972-
Thesis advisor Bendall, Sean, 1979-
Thesis advisor Engleman, Edgar G
Thesis advisor Levy, Ronald, 1941 December 6-
Degree committee member Bendall, Sean, 1979-
Degree committee member Engleman, Edgar G
Degree committee member Levy, Ronald, 1941 December 6-
Associated with Stanford University, Department of Immunology

Subjects

Genre Theses
Genre Text

Bibliographic information

Statement of responsibility Miles Hamilton Linde.
Note Submitted to the Department of Immunology.
Thesis Thesis Ph.D. Stanford University 2022.
Location https://purl.stanford.edu/hd601vf0379

Access conditions

Copyright
© 2022 by Miles Hamilton Linde

Also listed in

Loading usage metrics...